{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:48:31Z","timestamp":1790858911067,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"DOI":"10.13039\/100025503","name":"Foundation for Orthopedic Trauma","doi-asserted-by":"crossref","award":["7020-2"],"award-info":[{"award-number":["7020-2"]}],"id":[{"id":"10.13039\/100025503","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Despite advances in management, open fractures are at an elevated risk for deep fracture\u2013related infection (FRI). Time to systemic antibiotic (ABX) administration and intraoperative topical administration of ABX powder have been used to decrease FRI risk. The purpose of this study was to determine whether topical application of antibiotic powder to type III open lower extremity fractures immediately on presentation to the emergency department (ED) reduces the rate of FRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective cohort compared with retrospective historical control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Level I trauma center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention:<\/jats:title>\n                    <jats:p>Application of 1 g of vancomycin and 1.2 g of tobramycin powder directly to open fracture wounds on presentation to the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient Selection Criteria:<\/jats:title>\n                    <jats:p>Patients with type III open lower extremity fractures treated from July 1, 2019, to September 17, 2022, who received topical ABX powder in the ED were compared with patients from a 4-year historical cohort from July 1, 2015, to June 30, 2019, who were treated without topical ABX powder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome Measures and Comparisons:<\/jats:title>\n                    <jats:p>Development of a FRI within 6 months of follow-up. Patient demographics, injury characteristics, and postoperative data were analyzed as risk factors for FRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Sixty-six patients received topical ABX powder in the ED and were compared with 129 patients who were treated without topical ABX powder. The rate of FRI in the trial group was 6\/66 (9.09%) versus 22\/129 (17.05%) in the control cohort (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.133). Multivariate analysis demonstrated higher body mass index as a risk factor for development of FRI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.036).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>No statistically significant difference in rates of FRI in open lower extremity fractures treated with immediate topical ABX administration in the ED versus standard-of-care treatment without topical ABX was found. These findings may have been limited by insufficient power. Further large-scale study is warranted to determine the significance of topical antibiotic powder application in the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bot.0000000000002717","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:37Z","timestamp":1697673637000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The Effect of Topical Antibiotic Powder Application in the Emergency Department on Deep Fracture\u2013Related Infection in Type III Open Lower Extremity Fractures"],"prefix":"10.1097","volume":"38","author":[{"given":"Shea","family":"Taylor","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of South Florida, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"John","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of South Florida, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2995-3772","authenticated-orcid":false,"given":"Whisper","family":"Grayson","sequence":"additional","affiliation":[{"name":"Morsani College of Medicine, University of South Florida, Tampa, FL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-3468","authenticated-orcid":false,"given":"Hassan R.","family":"Mir","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of South Florida, Tampa, FL;"},{"name":"Orthopaedic Trauma Service, Florida Orthopaedic Institute, Tampa, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s11999-013-2855-4","article-title":"What is the rate of methicillin-resistant Staphylococcus aureus and Gram-negative infections in open fractures?","volume":"471","author":"Chen","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1056\/NEJMoa012604","article-title":"An analysis of outcomes of reconstruction or amputation of leg-threatening injuries","volume":"347","author":"Bosse","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/wound.2014.0531","article-title":"Current concepts and ongoing research in the prevention and treatment of open fracture infections","volume":"4","author":"Hannigan","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.injury.2011.12.007","article-title":"The epidemiology of open fractures in adults. A 15-year review","volume":"43","author":"Court-Brown","year":"2012","journal-title":"Injury"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/JBJS.K.00582","article-title":"Does timing to operative debridement affect infectious complications in open long-bone fractures? A systematic review","volume":"94","author":"Schenker","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1302\/0301-620X.100B11.BJJ-2018-0308.R1","article-title":"Economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb","volume":"100-B","author":"Parker","year":"2018","journal-title":"Bone Joint J"},{"key":"R7-20250614","first-page":"381706","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project","volume":"189","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R8-20250614","first-page":"172","article-title":"[Secondary amputation of the limb after primary surgery of open fractures of the lower limb]","volume":"29","author":"M'Bra","year":"2018","journal-title":"Pan Afr Med J"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2106\/00004623-197658040-00004","article-title":"Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses","volume":"58","author":"Gustilo","year":"1976","journal-title":"J Bone Joint Surg Am"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/TA.0000000000000205","article-title":"Open extremity fractures: impact of delay in operative debridement and irrigation","volume":"76","author":"Malhotra","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2011.06281.x","article-title":"New approaches for treating staphylococcal biofilm infections","volume":"1241","author":"Kiedrowski","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"R12-20250614","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0022-2015","article-title":"The staphylococcal biofilm: adhesins, regulation, and host response","volume":"4","author":"Paharik","year":"2016","journal-title":"Microbiol Spectr"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu Rev Microbiol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e091","DOI":"10.1097\/OI9.0000000000000091","article-title":"Early application of topical antibiotic powder in open-fracture wounds: a strategy to prevent biofilm formation and infections","volume":"3","author":"Burbank","year":"2020","journal-title":"OTA Int"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","article-title":"Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes","volume":"36","author":"Sweet","year":"2011","journal-title":"Spine"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/BOT.0000000000000617","article-title":"Time-dependent effectiveness of locally applied vancomycin powder in a contaminated traumatic orthopaedic wound model","volume":"30","author":"Tennent","year":"2016","journal-title":"J Orthop Trauma"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00003086-198906000-00006","article-title":"Factors influencing infection rate in open fracture wounds","volume":"243","author":"Patzakis","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1302\/0301-620X.94B1.27026","article-title":"Early antibiotics and debridement independently reduce infection in an open fracture model","volume":"94","author":"Penn-Barwell","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOT.0000000000000262","article-title":"Type III open tibia fractures: immediate antibiotic prophylaxis minimizes infection","volume":"29","author":"Lack","year":"2015","journal-title":"J Orthop Trauma"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2106\/JBJS.RVW.17.00197","article-title":"Antibiotic prophylaxis in the management of open fractures: a systematic survey of current practice and recommendations","volume":"7","author":"Chang","year":"2019","journal-title":"JBJS Rev"},{"key":"R21-20250614","first-page":"1781","article-title":"Classification of type III (severe) open fractures relative to treatment and results","volume":"10","author":"Gustilo","year":"1987","journal-title":"Orthopedics"},{"key":"R22-20250614","first-page":"102","article-title":"The role of local antibiotic therapy in the management of compound fractures","volume":"10","author":"Ostermann","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.injury.2021.08.028","article-title":"Intra-wound vancomycin and tobramycin powder for infection prophylaxis in orthopaedic trauma surgery: economically justifiable?","volume":"52","author":"Kirchner","year":"2021","journal-title":"Injury"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3171\/2013.6.SPINE121105","article-title":"Comparative effectiveness and cost-benefit analysis of local application of vancomycin powder in posterior spinal fusion for spine trauma","volume":"19","author":"Godil","year":"2013","journal-title":"J Neurosurg Spine"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"e207259","DOI":"10.1001\/jamasurg.2020.7259","article-title":"Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial","volume":"156","author":"O'Toole","year":"2021","journal-title":"JAMA Surg"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOT.0000000000001863","article-title":"Vancomycin powder use in fractures at high risk of surgical site infection","volume":"35","author":"Qadir","year":"2021","journal-title":"J Orthop Trauma"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/BOT.0000000000000941","article-title":"Intraoperative topical antibiotics for infection prophylaxis in pelvic and acetabular surgery","volume":"31","author":"Owen","year":"2017","journal-title":"J Orthop Trauma"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1302\/2046-3758.77.BJR-2018-0043.R1","article-title":"The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis","volume":"7","author":"Morgenstern","year":"2018","journal-title":"Bone Joint Res"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2106\/JBJS.O.00072","article-title":"Local injection of aminoglycosides for prophylaxis against infection in open fractures","volume":"97","author":"Lawing","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.idc.2005.08.001","article-title":"Management of open fractures","volume":"19","author":"Zalavras","year":"2005","journal-title":"Infect Dis Clin North Am"}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:03:39Z","timestamp":1749909819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000002717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000002717","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-10-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}